Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 26;77(11):1121-1130.
doi: 10.1136/thoraxjnl-2021-217979. Online ahead of print.

High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors

Collaborators, Affiliations

High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors

Bhim Gopal Dhoubhadel et al. Thorax. .

Abstract

Background: Multiple serotypes of pneumococci have epidemiological and clinical implications, such as the emergence of non-vaccine serotypes and the acquisition of antimicrobial resistance. Prevalence of multiple serotypes of pneumococci in adults and their risk factors are not known.

Methods: We enrolled adult patients from age ≥15 years with radiologically confirmed pneumonia in four hospitals across Japan. Pneumococcal pneumonia was defined with a pneumococcal bacterial density of ≥104/mL in sputum by lytA quantitative PCR, and serotypes were determined. Pneumonias with a single serotype were categorised as single-serotype pneumococcal pneumonia and with two or more serotypes as multiple-serotype pneumococcal pneumonia. Multivariable logistic regression was used to assess the risk factors.

Results: 3470 patients (median age 77 years, IQR 65-85) were enrolled. Pneumococcal pneumonia was identified in 476 (18.3%, n=2605) patients. Multiple serotypes were detected in 42% of them. Risk of having multiple serotypes was low among patients who had received 23-valent pneumococcal polysaccharide vaccine (PPSV23) vaccines (adjusted OR 0.51 (95% CI 0.27 to 0.94)). Proportion of non-PCV7 PPSV23 serotypes in overall distribution of multiple serotypes was 67.4% (n=324/481) compared with 46.4% (n=128/276) in that of single serotypes (p=0.001). Serotypes 5, 9N/9L, 10A, 12/22/46, 17F and 35F were associated with multiple-serotype pneumonia, and serotypes 6A/6B, 23F, 11 and 6C/6D were associated with single-serotype pneumonia. Proportion of more invasive serotypes (serotypes 1, 5, 7F, 8) was significantly higher in multiple-serotype pneumonia (p=0.001).

Conclusions: Multiple serotypes of pneumococci are common in sputum of adult patients with pneumonia. The risk of multiple-serotype pneumococcal pneumonia is lower than that of single-serotype pneumococcal pneumonia among PPSV23-vaccinated patients.

Trial registration number: UMIN000006909.

Keywords: bacterial infection; clinical epidemiology; pneumonia; respiratory infection.

PubMed Disclaimer

Conflict of interest statement

Competing interests: KA declares speaker fees from Eli Lilly, Takeda and Asahi Kasei Pharma. KM declares speaker fees from Pfizer and Kyorin Pharma. No other authors declare any competing interests.

Figures

Figure 1
Figure 1
Patient enrolment and identification of pneumococcal pneumonia. Flow chart shows the number of adult patients (≥15 years) from the enrolment to the identification of patients with single-serotype and multiple-serotype pneumococcal pneumonias.
Figure 2
Figure 2
Distribution of pneumonia in adults by age in Japan. Bar diagram shows the distribution of radiologically confirmed adult patients with pneumonia (black bar), single-serotype pneumococcal pneumonia (blue bar) and multiple-serotype pneumococcal pneumonia (green bar) by age group.
Figure 3
Figure 3
Distribution of pneumococcal serotypes. Bar diagram showing the distribution of pneumococcal serotype/serogroups in single-serotype pneumococcal pneumonia (number of serotypes=276) and multiple-serotype pneumococcal pneumonia (number of serotypes=481). Blue bar represents serotype distribution in single-serotype pneumonia, whereas orange, green and purple bars represent serotype distributions of first, second and third dominant serotypes in multiple-serotype pneumonia. PPSV23, 23-valent pneumococcal polysaccharide vaccine.
Figure 4
Figure 4
Bacterial density in single-serotype pneumococcal pneumonia and multiple-serotype pneumococcal pneumonia. Box and whisker plot showing the distribution of bacterial density of serotypes in single-serotype pneumococcal pneumonia and multiple-serotype pneumococcal pneumonia in order of dominance. The total number of serotypes identified was 242 in single-serotype pneumonia and 481 in multiple-serotype pneumonia.
Figure 5
Figure 5
Scatter plot showing the relationship between pneumococcal bacterial density and C-reactive protein in single-serotype pneumococcal pneumonia and multiple-serotype pneumococcal pneumonia. Solid lines represent the linear regression fit across the patients. Spearman’s rank correlation coefficients were 0.205 (p=0.001) and 0.184 (p=0.009) for single-serotype pneumococcal pneumonia and multiple-serotype pneumococcal pneumonia, respectively.

References

    1. Ladhani SN, Collins S, Djennad A, et al. . Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. Lancet Infect Dis 2018;18:441–51. 10.1016/S1473-3099(18)30052-5 - DOI - PubMed
    1. Hanquet G, Krizova P, Valentiner-Branth P, et al. . Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. Thorax 2019;74:473–82. 10.1136/thoraxjnl-2018-211767 - DOI - PMC - PubMed
    1. Demczuk WHB, Martin I, Desai S, et al. . Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016. Vaccine 2018;36:4701–7. 10.1016/j.vaccine.2018.06.018 - DOI - PubMed
    1. Menzies RI, Jardine A, McIntyre PB. Pneumonia in elderly Australians: reduction in presumptive pneumococcal hospitalizations but no change in all-cause pneumonia hospitalizations following 7-valent pneumococcal conjugate vaccination. Clin Infect Dis 2015;61:927–33. 10.1093/cid/civ429 - DOI - PubMed
    1. Sando E, Suzuki M, Furumoto A, et al. . Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: the Japan pneumococcal vaccine effectiveness study (J-PAVE). Vaccine 2019;37:2687–93. 10.1016/j.vaccine.2019.04.009 - DOI - PubMed